09-10, 15:00–16:00 (Europe/Istanbul), Humanitarian + Transverse Activities + Global Outreach
Head and Neck cancer: how to manage depending on resource availability? will be discussed.
I work at Eskişehir Osmangazi University Faculty of Medicine. My special interest is head and neck surgery.
After a career of over 30 years in the field of otolaryngology, when I reach the title Prof. Dr. in which I combined rigorous medical practice with teaching and scientific activity I extend my level of research. My deep interest in pediatric rhinology and ENT has developed over time, in response to the growing needs of patients and the specific challenges of these subspecialties. Rhinology, through the complexity of nasosinusal pathologies and continuous technological evolution, has motivated me to constantly follow the latest discoveries in the field. On the other hand, pediatric ENT represents a special mission for me, in which science is intertwined with empathy and responsibility towards the most vulnerable patients – children. I also actively participate in nasal allergy research, especially in pediatric patients.
Dr. Mark Zafereo is a Professor of Head and Neck Surgery at MD Anderson Cancer Center in Houston, Texas where he is Section Chief of Head and Neck Endocrine Surgery and Associate Medical Director of the Head & Neck Center. Dr. Zafereo serves as Treasurer of the American Thyroid Association, and on the American Head & Neck Society Research and Education Foundation Board of Trustees. He has previously served on the Board of Directors of the American Academy of Otolaryngology-Head and Neck Surgery, and the International Thyroid Oncology Group. Dr. Zafereo leads several national multicenter clinical trials on neoadjuvant therapy followed by surgery for advanced differentiated, medullary, and anaplastic thyroid cancers. He has published significantly on Thyroid and other Head & Neck cancers, speaking nationally and internationally. His clinical practice focuses on patients afflicted with thyroid cancer and parathyroid neoplasms.
- Clinical trials for advanced thyroid cancer: intergrating tumor genomics with targeted therapy and surgery
- Targeted Therapy in the Management of Thyroid Cancer
- American Academy of Otolaryngology: New technologies, advances and treatment strategies in Head and Neck Cancer
- Thyroid Surgery 2026: a joint session from the World Congress on Thyroid Cancer and the AHNS- Endocrine Section
- PAN AMERICAN PANEL: Treatment approaches in laryngeal cancer
- The Journal of Colleges of Medicne JCMSA: A model for sharing research from Low and Middle Income countries (LMICs)
- Global Perspectives on the Management of Thyroid Malignancies and Local Practices
- Access to High Quality Head and Neck Cancer Care: Challenges and Potential Solutions
- Challenges and solutions to Head and Neck Cancer care in Africa and in Lower- and Middle-Income countries
Nicolas Fakhry is a Professor of Otolaryngology – Head and Neck Surgery in Marseille, France. He is a referring surgeon for Head and Neck Surgery, Oncology and salivary glands tumors. As a clinician scientist, Nicolas Fakhry has more than 250 peer-reviewed publications and book chapters. He serves on many research committees and is a reviewer for multiple scientific journals. Nicolas Fakhry is a founding member and past president of the Young-IFOS and now member of the executive committee of IFOS. He is the President of the French Society of Head and Neck Cancer (SFCCF).